Novel Gene Translocations Involving TYK2 in Cutaneous CD30-Positive Lymphoproliferative Disorders

被引：0

作者：

Velusamy, Thirunavukkarasu ^{[1
]}

Kiel, Mark J. ^{[1
]}

Sahasrabuddhe, Anagh A. ^{[1
]}

Rolland, Delphine C. M. ^{[1
]}

Dixon, Catherine A. ^{[1
]}

Bailey, Nathanael G. ^{[1
]}

Betz, Bryan L. ^{[1
]}

Brown, Noah A. ^{[1
]}

Hristov, Alexandra C. ^{[1
]}

Wilcox, Ryan A. ^{[1
]}

Miranda, Roberto N. ^{[2
]}

Medeiros, L. Jeffrey ^{[2
]}

Jeon, Yoon K. ^{[3
]}

Lim, Megan S. ^{[1
]}

Elenitoba-Johnson, Kojo S. J. ^{[1
]}

机构：

[1] Univ Michigan, Ann Arbor, MI 48109 USA

[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[3] Seoul Natl Univ Hosp, Seoul 110744, South Korea

来源：

BLOOD | 2014年 / 124卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[31] The primary cutaneous CD30-positive lymphoproliferative diseases; the own observations of the center, prospects of therapy
Gorenkova, Liliya
Belousova, Irena
Kravchenko, Sergey
EUROPEAN JOURNAL OF CANCER, 2021, 156 : S56 - S56
[32] Cutaneous CD30-positive T-cell lymphoproliferative disorders-clinical and histopathologic features, differential diagnosis, and treatment
Kempf, Werner
Kerl, Katrin
Mitteldorf, Christina
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2018, 37 (01) : 24 - 29
[33] Endogenous retroviral elements, but not exogenous retroviruses, are detected in CD30-positive lymphoproliferative disorders of the skin
Kempf, W
Kadin, ME
Dvorak, AM
Lord, CC
Burg, G
Letvin, NL
Koralnik, IJ
CARCINOGENESIS, 2003, 24 (02) : 301 - 306
[34] Primary cutaneous CD30+ lymphoproliferative disorders with DUSP22 translocation; [Primär kutane CD30-positive lymphoproliferative Erkrankungen mit DUSP22-Translokation]
Montes-Moreno S.
Die Pathologie, 2023, 44 (Suppl 3) : 136 - 139
[35] Th2 cytokine mrna expression in primary cutaneous CD30-positive lymphoproliferative disorders: Successful treatment with recombinant interferon-gamma.
Yagi, H
Tokura, Y
Furukawa, F
Takigawa, M
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 106 (04) : 691 - 691
[36] Immunohistochemical analysis of CD30-positive lymphoproliferative disorders for expression of CD95 and CD95L
Sigel, JE
Hsi, ED
MODERN PATHOLOGY, 2000, 13 (04) : 446 - 451
[37] Recurrence of primary cutaneous CD30-positive lymphoproliferative disorder following COVID-19 vaccination
Brumfiel, Caitlin M.
Patel, Meera H.
DiCaudo, David J.
Rosenthal, Allison C.
Pittelkow, Mark R.
Mangold, Aaron R.
LEUKEMIA & LYMPHOMA, 2021, 62 (10) : 2554 - 2555
[38] Th2 cytokine mRNA expression in primary cutaneous CD30-positive lymphoproliferative disorders: Successful treatment with recombinant interferon-gamma
Yagi, H
Tokura, Y
Furukawa, F
Takigawa, M
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 107 (06) : 827 - 832
[39] Primary Mucosal CD30-Positive T-Cell Lymphoproliferative Disorders Have Clinicopathologic Features Similar to Primary Cutaneous Cases
Sciallis, A. P.
Law, M. E.
Inwards, D. J.
Macon, W. R.
Dogan, A.
Feldman, A. L.
LABORATORY INVESTIGATION, 2011, 91 : 320A - 320A
[40] Primary Mucosal CD30-Positive T-Cell Lymphoproliferative Disorders Have Clinicopathologic Features Similar to Primary Cutaneous Cases
Sciallis, A. P.
Law, M. E.
Inwards, D. J.
Macon, W. R.
Dogan, A.
Feldman, A. L.
MODERN PATHOLOGY, 2011, 24 : 320A - 320A

← 1 2 3 4 5 →